Marvell Technology Inc vs Vital Farms Inc — how do they compare? Marvell Technology Inc trades at $231.81 (market cap $200.91B), while Vital Farms Inc trades at $9.81 (market cap $432.32M). The key difference: Marvell Technology Inc is far larger — about 464.7× Vital Farms Inc's market cap, and Marvell Technology Inc pays a 0.11% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| MRVL | VITL | |
|---|---|---|
Market Cap | $200.91B | $432.32M |
Sector | Technology | Consumer Staples |
52-Week High | $316.43 | $48.56 |
52-Week Low | $66.59 | $8.28 |
Enterprise Value | $202.26B | $519.33M |
Dividend Yield | 0.11% | — |
Signals from Pluang's Aura AI — not financial advice
Marvell Technology (MRVL) trades at $225.41, up 0.83% with strong technical momentum and bullish moving average signals. The company demonstrates robust revenue growth with Q2 2026 EPS beating expectations at $0.94 versus $0.934, while management projects revenue reaching $12 billion this fiscal year and $18 billion next year. Analyst consensus remains overwhelmingly positive with 82% buy ratings and a $303.11 price target, representing 35% upside potential from current levels.
Marvell's AI-driven growth trajectory presents significant opportunity, though investors face risks from high valuation multiples (P/E 74.02) and competitive pressures in the semiconductor space. The stock's recent 31% pullback from yearly highs offers potential entry point for growth-oriented investors, supported by strong institutional accumulation and positive earnings momentum heading into October's Investor Day event.
Vital Farms (VITL) trades at $10.08, up 1.61% on the day, but faces bearish technical signals with key support at $9. The company reported a challenging Q2 2026 with a net loss per share of $0.47, though revenue of $166 million slightly beat expectations. Gross margin collapsed to 6.6% amid industry oversupply, but management reaffirmed full-year guidance and secured a $125 million term loan for stability.
The outlook is cautious; analyst consensus is a Buy with a $13.00 price target, but near-term risks include persistent margin pressure, cash burn, and competitive pricing gaps. Long-term recovery depends on execution against guidance and market stabilization.
Trailing returns across standard periods
Latest headlines on both assets
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →